Nanosensors support skin cancer therapy

 
By 18 February 2013
SHARE :

Malignant melanoma is the most aggressive type of skin cancer. In more than 50 percent of affected patients a particular mutation plays an important role. As the life span of the patients carrying the mutation can be significantly extended by novel drugs, it is very important to identify those reliably. For identification, researchers in Switzerland have developed a novel method.
(read here…)